GB202020502D0
|
|
Antibody composistion for treatment of corona virus infection
|
GB202020508D0
|
|
Multivalent sars-cov-2 virus binders
|
GB202019127D0
|
|
A drosophila suzukii specific trap
|
GB202019132D0
|
|
Improved insect attractants
|
WO2021078786A1
|
|
Nanodisc-specific antigen-binding chimeric proteins
|
GB202015082D0
|
|
Combination of P2Y6 inhibitors and immune checkpoint inhibitors
|
GB202012530D0
|
|
Low phosphate tolerant plants
|
WO2020254364A1
|
|
Predicting chronic allograft injury through age-related dna methylation
|
WO2020239934A1
|
|
Cd8+ t-cells lacking plexins and their application in cancer treatment
|
WO2020239945A1
|
|
Cancer treatment by targeting plexins in the immune compartment
|
GB202006786D0
|
|
Means and methods to treat viral infections
|
WO2020221888A1
|
|
Cystic fibrosis transmembrane conductance regulator stabilizing agents
|
WO2020182615A1
|
|
Crystal structure of atp citrate lyase and uses thereof
|
GB202002463D0
|
|
Targeting of nuclear receptor heterodimers
|
WO2020165361A1
|
|
Retrotransposon biomarkers
|
GB202001660D0
|
|
Vaccine adjuvant conjugates
|
WO2020127983A1
|
|
Fusion proteins comprising a cytokine and scaffold protein
|
WO2020127993A1
|
|
Fusion protein with a toxin and scaffold protein
|
GB201918279D0
|
|
Glycosylated single chain immunoglobulin domains
|
GB201918108D0
|
|
Improved aminopeptiadases for single molecule peptide sequencing
|